FactSet (NYSE:FDS) Stock Analysis: UBS Price Target Contrasts Strong Earnings Growth

• A UBS analyst set a cautious price target of $237.00 for FactSet, implying a 12.21% potential downside from its trading price of $269.95.
• FactSet reported strong Q4 adjusted earnings per share (EPS) of $4.52, an 11.6% increase year-over-year, and revenue of $634.70 million, exceeding analyst estimates.
• Despite the cautious analyst view, FactSet shows robust organic Annual Subscription Value (ASV) growth and is considered "Significantly Undervalued" by GuruFocus with a GF Value of $523.08.

FactSet (NYSE:FDS) is a leading financial data and analytics company. It provides essential data and software solutions to the global investment community, including asset managers and hedge funds. The company primarily generates revenue through subscriptions for its platform, which offers tools for portfolio analytics, risk management, and research.

The main point of interest in recent stock analysis is a price target set by a UBS analyst on September 30, 2026. The analyst set a target of $237.00 for FactSet when the stock was trading at $269.95. This new target represents a potential downside of approximately 12.21% from its price when the target was issued.

This cautious view contrasts with FactSet's strong recent market performance. For its fourth quarter, FactSet reported adjusted earnings per share (EPS) of $4.52. This is an 11.6% increase from the previous year and beats the Zacks Consensus Estimate of $4.32, as highlighted by Zacks Investment Research.

Revenue growth also showed healthy expansion, climbing 6.3% year-over-year to $634.70 million, which was above the consensus estimate of $628.20 million. A key driver was a 7% increase in organic Annual Subscription Value (ASV), which reached $2.57 billion, showing strong demand for its core subscription services.

Despite the strong adjusted earnings, FactSet's reported diluted EPS of $3.41 missed some analyst estimates. However, GuruFocus gives FactSet a GF Score of 93 out of 100 and considers it "Significantly Undervalued" with a GF Value of $523.08, presenting a different view from the UBS target on stock valuation.